Research Article

THE ROLE OF NEUTROPHIL TO LYMPHOCYTE RATIO AND PLATELET TO LYMPHOCYTE RATION IN DIAGNOSIS OF SUBACUTE THYROIDITIS

Volume: 4 Number: 1 April 30, 2022
EN

THE ROLE OF NEUTROPHIL TO LYMPHOCYTE RATIO AND PLATELET TO LYMPHOCYTE RATION IN DIAGNOSIS OF SUBACUTE THYROIDITIS

Abstract

Purpose: Patients with subacute thyroiditis (SAT) usually apply to clinics with thyrotoxicosis and neck pain. Hemogram is frequently applied tests in primary health care services, and it can warn physicians for SAT in a thyrotoxic patient. In our study, the role and usability of neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) in the diagnosis of SAT were evaluated. Material and Methods: Between January 2015 and January 2020, 192 SAT patients who applied to endocrinology clinics and 85 healthy control were included in the study. Neutrophil (Neu), lymphocyte (Lym), platelet (PLT) leves were recorded. Results: The median NLR and PLR values of SAT patients before treatment were 2.78 (0.91-11.33) and 168.3 (25.7-818.3), respectively, and were significantly higher than the control group (p<0.001). The optimum cut-off values for NLR and PLR for SAT were 1.84 (specificity 85.9% and sensitivity 90.1%; p<0.001; AUC=0.934; 95% CI: 0.905-0.964 ) and 140.2 (specificity 83.5% and sensitivity 77.1%, p<0.001, AUC=0.821 95% CI: 0.767-0.874), respectively. Pretreatment NLR, PLR, CRP, and ESR levels were significantly higher than the posttreatment levels (all p<0.001). Correlation analysis revealed positive linear relations between pretreatment PLR and CRP (p=0.002, r=0.220), pretreatment PLR and ESR (p=0.018, r=0.171), pretreatment NLR and CRP (p<0.001, r=0.330), and pretreatment NLR and ESR (p=0.001, r=0.242). Multiple linear regression analysis revealed a 0.008 unit of increment of NLR per 1 unit increase in CRP levels (B=0.008; p<0.001; %95 CI=0.004-0.012). Conclusion: High NLR and PLR values accompanying thyrotoxicosis are both warning and helpful parameters for the diagnosis of SAT.

Keywords

References

  1. Ahsen, A., Ulu, M. S., Yuksel, S., Demir, K., Uysal, M., Erdogan, M., & Acarturk, G. (2013). As a new inflammatory marker for familial Mediterranean fever: neutrophil-to-lymphocyte ratio. Inflammation, 36(6), 1357-1362. doi:10.1007/s10753-013-9675-2
  2. Azab, B., Jaglall, N., Atallah, J. P., Lamet, A., Raja-Surya, V., Farah, B., . . . Widmann, W. D. (2011). Neutrophil-lymphocyte ratio as a predictor of adverse outcomes of acute pancreatitis. Pancreatology, 11(4), 445-452. doi:10.1159/000331494
  3. Benbassat, C. A., Olchovsky, D., Tsvetov, G., & Shimon, I. (2007). Subacute thyroiditis: clinical characteristics and treatment outcome in fifty-six consecutive patients diagnosed between 1999 and 2005. J Endocrinol Invest, 30(8), 631-635. doi:10.1007/bf03347442
  4. Calapkulu, M., Sencar, M. E., Sakiz, D., Duger, H., Ozturk Unsal, I., Ozbek, M., & Cakal, E. (2020). The prognostic and diagnostic use of hematological parameters in subacute thyroiditis patients. Endocrine, 68(1), 138-143. doi:10.1007/s12020-019-02163-w
  5. Cengiz, H., Varim, C., Demirci, T., & Cetin, S. (2020). Hemogram parameters in the patients with subacute thyroiditis. Pak J Med Sci, 36(2), 240-245. doi:10.12669/pjms.36.2.1063
  6. Desailloud, R., & Hober, D. (2009). Viruses and thyroiditis: an update. Virol J, 6, 5. doi:10.1186/1743-422x-6-5
  7. Gabay, C., & Kushner, I. (1999). Acute-phase proteins and other systemic responses to inflammation. N Engl J Med, 340(6), 448-454. doi:10.1056/nejm199902113400607
  8. Gasparyan, A. Y., Ayvazyan, L., Mukanova, U., Yessirkepov, M., & Kitas, G. D. (2019). The Platelet-to-Lymphocyte Ratio as an Inflammatory Marker in Rheumatic Diseases. Ann Lab Med, 39(4), 345-357. doi:10.3343/alm.2019.39.4.345

Details

Primary Language

English

Subjects

Clinical Sciences

Journal Section

Research Article

Publication Date

April 30, 2022

Submission Date

April 1, 2022

Acceptance Date

April 27, 2022

Published in Issue

Year 2022 Volume: 4 Number: 1

APA
Tura Bahadır, Ç., Yılmaz, M., & Kılıç Kan, E. (2022). THE ROLE OF NEUTROPHIL TO LYMPHOCYTE RATIO AND PLATELET TO LYMPHOCYTE RATION IN DIAGNOSIS OF SUBACUTE THYROIDITIS. Sabuncuoglu Serefeddin Health Sciences, 4(1), 46-57. https://doi.org/10.55895/sshs.1096999
AMA
1.Tura Bahadır Ç, Yılmaz M, Kılıç Kan E. THE ROLE OF NEUTROPHIL TO LYMPHOCYTE RATIO AND PLATELET TO LYMPHOCYTE RATION IN DIAGNOSIS OF SUBACUTE THYROIDITIS. SSHS. 2022;4(1):46-57. doi:10.55895/sshs.1096999
Chicago
Tura Bahadır, Çiğdem, Merve Yılmaz, and Elif Kılıç Kan. 2022. “THE ROLE OF NEUTROPHIL TO LYMPHOCYTE RATIO AND PLATELET TO LYMPHOCYTE RATION IN DIAGNOSIS OF SUBACUTE THYROIDITIS”. Sabuncuoglu Serefeddin Health Sciences 4 (1): 46-57. https://doi.org/10.55895/sshs.1096999.
EndNote
Tura Bahadır Ç, Yılmaz M, Kılıç Kan E (April 1, 2022) THE ROLE OF NEUTROPHIL TO LYMPHOCYTE RATIO AND PLATELET TO LYMPHOCYTE RATION IN DIAGNOSIS OF SUBACUTE THYROIDITIS. Sabuncuoglu Serefeddin Health Sciences 4 1 46–57.
IEEE
[1]Ç. Tura Bahadır, M. Yılmaz, and E. Kılıç Kan, “THE ROLE OF NEUTROPHIL TO LYMPHOCYTE RATIO AND PLATELET TO LYMPHOCYTE RATION IN DIAGNOSIS OF SUBACUTE THYROIDITIS”, SSHS, vol. 4, no. 1, pp. 46–57, Apr. 2022, doi: 10.55895/sshs.1096999.
ISNAD
Tura Bahadır, Çiğdem - Yılmaz, Merve - Kılıç Kan, Elif. “THE ROLE OF NEUTROPHIL TO LYMPHOCYTE RATIO AND PLATELET TO LYMPHOCYTE RATION IN DIAGNOSIS OF SUBACUTE THYROIDITIS”. Sabuncuoglu Serefeddin Health Sciences 4/1 (April 1, 2022): 46-57. https://doi.org/10.55895/sshs.1096999.
JAMA
1.Tura Bahadır Ç, Yılmaz M, Kılıç Kan E. THE ROLE OF NEUTROPHIL TO LYMPHOCYTE RATIO AND PLATELET TO LYMPHOCYTE RATION IN DIAGNOSIS OF SUBACUTE THYROIDITIS. SSHS. 2022;4:46–57.
MLA
Tura Bahadır, Çiğdem, et al. “THE ROLE OF NEUTROPHIL TO LYMPHOCYTE RATIO AND PLATELET TO LYMPHOCYTE RATION IN DIAGNOSIS OF SUBACUTE THYROIDITIS”. Sabuncuoglu Serefeddin Health Sciences, vol. 4, no. 1, Apr. 2022, pp. 46-57, doi:10.55895/sshs.1096999.
Vancouver
1.Çiğdem Tura Bahadır, Merve Yılmaz, Elif Kılıç Kan. THE ROLE OF NEUTROPHIL TO LYMPHOCYTE RATIO AND PLATELET TO LYMPHOCYTE RATION IN DIAGNOSIS OF SUBACUTE THYROIDITIS. SSHS. 2022 Apr. 1;4(1):46-57. doi:10.55895/sshs.1096999

Cited By

               34329                            
34328
 

This journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.